Composition of three essential oils, and their mammalian cell toxicity and antimycobacterial activity against drug resistant-tuberculosis and nontuberculous mycobacteria strains.

Authors: Bueno J,Escobar P,Martínez JR,Leal SM,Stashenko EE,
Address: Grupo de Micobacterias, Subdirección Red Nacional de Laboratorios, Instituto Nacional de Salud, Bogotá, D.C., Centro Colombiano de Investigación en Tuberculosis CCITB, Colombia. jbueno@ins.gov.co
Journal:


Publication:

abstract

tuberculosis (TB) is the most ancient epidemic disease in the world and a serious opportunistic disease in HIV/AIDS patients. The increase in multidrug resistant Mycobacterium tuberculosis (MDR-TB, XDR-TB) demands the search for novel antimycobacterial drugs. essential oils (EOs) have been widely used in medicine and some EOs and their major components have been shown to be active against M. tuberculosis. The aim of this work was to evaluate the antimycobacterial and cell toxicity activities of three EOs derived from Salvia aratocensis, Turnera diffusa and Lippia americana, aromatics plants collected in Colombia. The EOs were isolated by hydrodistillation and analyzed by GC/MS techniques. The EOs were tested against 15 Mycobacterium spp using a colorimetric macrodilution method and against mammalian Vero and THP-1 cells by MTT. The activity was expressed as minimal concentration in microg/mL that inhibits growth, and the concentration that is cytotoxic for 50 or 90% of the cells (CC50 and CC90). The major components were epi-alpha-cadinol (20.1%) and 1,10-di-epi-cubenol (14.2%) for Salvia aratocensis; drima-7,9(11)-diene (22.9%) and viridiflorene (6.6%) for Turnera diffusa; and germacrene D (15.4%) and trans-beta- caryophyllene (11.3%) for Lippia americana. The most active EO was obtained from S. aratocensis, with MIC values below 125 microg mL(-1) for M. tuberculosis Beijing genotype strains, and 200 to 500 microg mL(-1) for nontuberculous mycobacterial strains. The EOs were either partially or non toxic to Vero and THP-1 mammalian cells with CC50 values from 30 to > 100 microg mL(-1), and a CC90 > 100 microg mL(-1). The EOs obtained from the three aromatic Colombian plants are an important source of potential compounds against TB. Future studies using the major EO components are recommended.



Related Articles
Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components.
Mem Inst Oswaldo Cruz. 2010
Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components.
Escobar P, Milena Leal S, Herrera LV, Martinez JR, Stashenko E. Mem Inst Oswaldo Cruz. 2010 Mar; 105(2):184-90.
Review [Development of antituberculous drugs: current status and future prospects].
Kekkaku. 2006
Review [Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K. Kekkaku. 2006 Dec; 81(12):753-74.
Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).
J Ethnopharmacol. 2009
Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).
Gordien AY, Gray AI, Franzblau SG, Seidel V. J Ethnopharmacol. 2009 Dec 10; 126(3):500-5. Epub 2009 Sep 13.
In vitro and in vivo antimalarial activity of essential oils and chemical components from three medicinal plants found in northeastern Brazil.
Planta Med. 2012
In vitro and in vivo antimalarial activity of essential oils and chemical components from three medicinal plants found in northeastern Brazil.
Mota ML, Lobo LT, Costa JM, Costa LS, Rocha HA, Rocha e Silva LF, Pohlit AM, Neto VF. Planta Med. 2012 May; 78(7):658-64. Epub 2012 Mar 22.
Review [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
Kekkaku. 1998
Review [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
Kawahara S, Nagare H. Kekkaku. 1998 Feb; 73(2):77-82.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.